IP Library Granted Patent US 8,911,492
Granted Patent B2
US 8,911,492 · App. 13/751,997 · Granted Dec 16, 2014

Coating for a medical device having an anti-thrombotic conjugate

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,911,492
App. No.
13/751,997
Granted
Dec 16, 2014
Kind
B2
Abstract

An implantable device having a coating comprising a comb-type anti-thrombotic conjugate to prevent or reduce the formation of thrombosis on the surface of the device. The device includes a frame expandable from a first diameter to a second diameter wherein the frame has an inner surface and an outer surface, a plurality of structural features disposed along the frame and a plurality of polymer anti-thrombotic conjugate particles situated with the plurality of structural features. The particle can be created utilizing the comb type polymer and heparin conjugate as a carrier for a therapeutic agent within its polymer matrix. The structural features allow for particles having differing properties to be placed at various locations along the device. Moreover, particles having at least two different agents can be located within the same structural feature.

Claims (13)

1. An apparatus comprising:

a frame expandable from a first diameter to a second diameter wherein the frame has an inner surface and an outer surface, the distance between the surfaces defining the wall thickness of the frame;

a plurality of structural features disposed along the frame; and

a plurality of polymer anti-thrombotic conjugate particles situated with the plurality of structural features, wherein the anti-thrombotic conjugate comprises a biocompatible, bioabsorbable, hydrophobic polymer backbone having hydrophilic, antithrombotic end groups configured as an amphiphilic structure, the material having the following structure:

wherein n is an integer of 2-1000; and m is an integer of 100 to 5000; LA is repeating unit of lactic acid; SA is succinic acid; Hp is unmodified heparin conjugated to the material, the lactic acid, the succinic acid and the unmodified heparin form an integral part of the amphiphilic material the overall structure being comb-like in shape.

2. The apparatus of claim 1 wherein the plurality of structural features comprise ridges disposed on the surface of the frame.

3. The apparatus of claim 1 wherein the plurality of structural features comprises a plurality of wells formed in the frame.

4. The apparatus of claim 3 wherein the wells extend from the outer surface to the inner surface.

5. The apparatus of claim 3 wherein the plurality of wells is filled with the particles.

6. The apparatus of claim 1 wherein the plurality of polymer anti-thrombotic conjugate particles serves as a carrier for a therapeutic agent.

7. The apparatus of claim 1 wherein the plurality of particles comprises micro-particles.

8. The apparatus of claim 1 wherein the plurality of particles comprises nano-particles.

9. The apparatus of claim 1 further comprising an anti-thrombotic coating applied to the surface of the frame.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2025
From: CARDINAL HEALTH SWITZERLAND 515 GMBH; CARDINAL HEALTH 529, LLC; CORDIS CORPORATION; FLEXIBLE STENTING SOLUTIONS, INC
To: CORDIS US CORP
Reel/Frame 072987/0675 →
SECURITY INTEREST Recorded Oct 1, 2025
From: CORDIS US CORP.; ACCESS CLOSURE, LLC
To: HPS INVESTMENT PARTNERS, LLC
Reel/Frame 072973/0157 →